Next year´s breakpoint table, v 12.0 , is on consultation from 3 - 20 December 2021
Get to know moreWarning issued concerning cefiderocol susceptibility testing : there is currently no commercially available functioning test for cefiderocol MIC determination. EUCAST has investigated those available and all have problems with accuracy, reproducibility, bias and/or for some, with skipped wells. For…
Get to know moreBreakpoint table v 13.0 , dosing table v 13.0 and QC tables v 13.0 (2023) published.
Get to know moreRAST breakpoints and methods were developed further to include Salmonella enterica in systemic infections. Some QC criteria were also updated.
Get to know moreProposed breakpoints for infective endocarditis (14 Sept - 25Oct, 2024). Use the EUCAST form for comments to consultations .
Get to know moreComments and EUCAST responses to the open consultations on Brucella melitensis and Bacillus anthracis proposed breakpoints and methods are now published.
Get to know moreDocuments (breakpoint tables, methods and FAQs) related to Rapid Antimicrobial Susceptibility Testing directly from positive blood culture bottles have been revised.
Get to know moreThe guidance document on " What to do when there are no breakpoints " has been updated with recommendations for cefiderocol.
Get to know moreAminoglycoside breakpoints – the EUCAST approach and what this means for the clinician. C. Giske et al, 2025. Abstract in CMI.
Get to know moreOptimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring; Boston, United States, 9 – 10 October 2023.
Get to know more